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Background: Despite huge public campaigns, there is still overconsumption of antibiotics in children with self-limiting
diseases. Possible explanations may be the physicians’ and parents’ uncertainty about the gravity of the disease and
inadequate communication between physicians and parents leading to lack of reassurance for the parents. In this paper
we describe the design and methods of a trial aiming to rationalize antibiotic prescribing by decreasing this uncertainty
and parental anxiety.
Methods/Design: Acutely ill children without suspected serious disease consulting their family physician will be
consecutively included in a four-armed cluster randomized factorial controlled trial. The intervention will consist a
Point-of-Care C-reactive protein test and/or a brief intervention with safety net advice. The control group will receive
usual care. We intend to include 2560 patients in 88 family practices. Patients will be followed up until cure. The primary
outcome measure is the immediate antibiotic prescribing rate. Secondary outcomes are: comparison between groups
of speed of clinical recovery, parental concern, parental perception of the quality of the communication, parental
satisfaction, use of medication, use of diagnostic tests and medical services during the illness episode, and
cost-effectiveness of the interventions. Besides this, we will observationally analyse data of the children included
in the large ERNIE2-trial, but excluded in the cluster randomized trial, namely children suspected of serious disease
presenting in primary care and children who initially present at the out-patient paediatric clinic or emergency
department. We will search for predictors of antibiotic prescribing, speed of clinical recovery, parental concern,
parental perception of communication, parental satisfaction, use of medication, diagnostic tests and medical services.
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Discussion: This is a unique multifaceted intervention, in that it targets both physicians and parents by aiming
specifically at their uncertainty and concerns during the consultation. Both interventions are easy to implement
without special training. When proven effective, they could offer a feasible way to decrease inappropriate antibiotic
prescribing for children in family practice and thus avoid emergence of bacterial resistance, side effects and
unnecessary healthcare costs. Moreover, the observational part of the study will increase our insight in the course,
management and parent’s concern of acute illness in children.
Trial registration: ClinicalTrials.gov Identifier: NCT02024282.
Keywords: Child, Infant, Acute disease, Anti-bacterial agents/economics/, Anti-bacterial agents/therapeutic use, C-reactive
protein/analysis, Cluster analysis, Communication, Parent satisfaction, Physician's practice patterns, Point-of-care systemsBackground
Acute illness is a common reason for encounter of chil-
dren in family practice. The large majority of these chil-
dren suffer from non-serious, self-limiting conditions. Less
than 1% of acutely ill children visiting their family phys-
ician (FP) will have a serious illness [1]. Yet, many of these
children will be treated with antibiotics; a Belgian continu-
ous and integrated computerized morbidity registration
network (Intego) [2] shows that about 45% of all children
with an respiratory tract infection visiting their family
physician receive an antibiotic prescription. This is still far
too many and may lead to unnecessary adverse effects and
costs, and to the emergence of antibiotic resistance. This
overprescribing could partly be a reflection of the clini-
cian’s diagnostic uncertainty and fear to deny antibiotics
to a child with a serious bacterial infection. Another
explanation may be the difficulty family physicians
experience in convincing parents who are expecting
antibiotics, that it is unnecessary.
Physicians’ diagnostic uncertainty
In clinical practice, physicians can never guarantee that
a child will recover as expected. There is always a small,
but real, chance of complications. This uncertainty is
uncomfortable: they fear being too late when the condi-
tion of the child deteriorates. Prescribing antibiotics in
hope of preventing a bad outcome is one way of dealing
with this uncertainty [3]. Previous research showed that
physicians prescribe antibiotics more frequently when
it is difficult to distinguish viral form bacterial causes
[4-6]. A test helping to make this distinction may de-
crease antibiotic prescribing.
Another way to cope with uncertainty is creating a
safety net, enabling parents to contact the physician
promptly when the condition gets worse [7].
Misconceptions of worried parents
Research has shown that there are many misconceptions
about fever and its treatment. Parents expect symptom
relief for their ill child and see antibiotics as the most
potent treatment for this. They consider the severity andthe impact of the illness on their child as more import-
ant grounds to prescribe antibiotics than its cause. In
this mindset, any illness will improve quicker with anti-
biotics. When the physician does not prescribe antibi-
otics, some parents feel that their concerns have not
been taking seriously [8].
Most parents understand that taking antibiotics too
often could give problems including resistance or im-
munity, but only one out of three parents is worried
their child is getting too many antibiotics. A minority of
parents finds that the physician unjustifiably did not pre-
scribe antibiotics to their child, or conversely, that the
physician prescribed antibiotics unnecessarily [9].
These misconceptions can lead to pressure on physi-
cians during the consultation. Previous research showed
that physicians prescribe antibiotics more frequently
when they think that patients expect antibiotics [10-12]
or feel pressured by the patient or parent [9,10,13,14].
Miscommunication between physicians and parents
Physicians fail to communicate to parents how they as-
sess an ill child and why they sometimes prescribe symp-
tomatic treatments and at other times antibiotics. The
well-intented quote “it’s a virus”, meant to soothe par-
ents, is often interpreted as “the physician is unsure”.
This increases the anxiety and the need for a second
opinion. The anxiety grows further when different physi-
cians express divergent opinions [8,15].
Parents on the other hand fail to communicate their real
concerns. Often they are very worried: they feel responsible
for the wellbeing of their child and are afraid it will die or
be irreversibly damaged. They visit the physician because
they feel out of control, want to share the responsibility for
the child and regain control [16]. Yet, they often feel un-
comfortable or lack the confidence to express their anxiety
and ask the physician questions about the treatment [8].
Moreover, parents are often in a dilemma as to when to
seek advice: when the physician advises to wait and see,
they feel they consulted too early and bothered the phys-
ician unnecessarily, but on the other hand, when the phys-
ician says they should have come earlier, they feel guilty [8].
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Research shows that parents search for specific and
practical information about how to care for their ill
child, how to evaluate the cause and the severity of the
illness, and the need for professional advice. They also
want information about the illness, the most appropri-
ate treatment and how to prevent their child from fall-
ing ill again. Parents think that being better informed
could reduce their fears [8].
In this trial, we intend to evaluate the effect of a
Point-of-Care (POC) C-reactive protein (CRP) test and
a brief intervention combined with written safety net
advice on the antibiotic prescribing rate in acutely ill chil-
dren not suspected of serious disease in primary care.
Our hypothesis is that an objective technical tool, im-
proved communication and provision of clear informa-
tion for parents will decrease both the physician’s and
parent’s uncertainty, increase their mutual understanding
and thus decrease the need for an antibiotic prescription.
This trial is part of the ERNIE2-trial, which also compre-
hends a diagnostic study, validating vital signs, a symptom
decision tree, a POC CRP-test and oxygen saturation in
seriously ill children in urgent-access care [17].
Research questions and outcome measures
Does performing a POC CRP test and a brief intervention
with safety net advice in acutely ill children not suspected
of serious disease in primary care, either separately or
combined, have an effect on:
Primary outcome measure
Immediate antibiotic prescribing rate
Secondary outcome measures
1. Clinical recovery
2. Parental concern
3. Parental perception of communication
4. Parental satisfaction
5. Use of medication, diagnostic tests and medical
services (including re-consultation) during the illness
episode
6. Cost-effectiveness of point-of-care CRP testing, brief
intervention with safety net advice
We will also collect observational data of the children
included in the large ERNIE2-trial, but excluded in the
cluster randomized trial, i.e. (1) children suspected of
serious disease presenting in primary care and (2) chil-
dren who initially present at the out-patient paediatric
clinic or emergency department. We will search this
data for predictors of antibiotic prescribing, speed of
clinical recovery, parental concern, parental perception of
communication, parental satisfaction, use of medication,diagnostic tests and medical services (including re-
consultation) during the illness episode.
Ethical approval
The protocol of this study was approved by the Ethical
Review Board of the University Hospitals/KU Leuven,
under reference ML8601. For more details, we refer to
Verbakel et al. [17].
Methods
The methodology is described according to the Consort
2010 statement for the reporting of cluster randomized
trials [18].
Design
We intend to perform a cluster randomized, factorial
controlled trial in acutely ill children not suspected of
serious disease presenting to a family physician (primary
care). We will use a 2 × 2 factorial design to assess the
effect of each intervention and to explore the effect of
the interventions combined. There are four allocation
groups, consisting of family physicians (1) using a POC
CRP test, (2) applying a brief intervention with safety
net advice, (3) using POC CRP test plus applying a brief
intervention with safety net advice and (4) usual care
(Figure one, Verbakel et al. [17]).
Besides this, we will also perform an observational
study in children suspected of serious disease presenting
in primary care and children who initially present at the
out-patient paediatric clinic or emergency department.
Participants
Clusters
The clustered trial includes family practices in Flanders
(Belgium).
There is only one eligibility criterion: being able to re-
cruit children consecutively during the inclusion period.
Patients
Children aged 1 month to 16 years, presenting to a FP
(primary care) with an acute illness episode of maximum
5 days and scoring negative on a 5-stage decision tree
(in order to exclude children with a potentially serious
illness) will be included consecutively in the cluster ran-
domized trial.
For more details about the decision tree and exclusion
criteria, we refer to Verbakel et al. [17].
Children excluded in the cluster randomized trial, but
included in the large ERNIE2-trial, will be included in
the observational study.
Interventions
Children included in the cluster randomized trial will
receive the following interventions depending on the
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(group 1), or a brief intervention with safety net advice
(group 2), or both (group 3), or none (group 4).(I) POC CRP test (finger prick)
As POC CRP test, we chose the Afinion CRP test (the
Afinion AS100 Analyzer, Alere, USA). For the rationale
of this choice and details on the test’s performance and
practical applications, we refer to Verbakel et al. [17].
All physicians will be instructed in performing the POC
CRP test.(II) Brief intervention with safety net advice
Brief intervention As brief intervention the FP will ask
the following three questions to the parents, namely:
“Are you concerned?”, “What exactly concerns you?”
and “Why does this concern you?”. This intervention
was extensively piloted in different training practices, to
guarantee that these questions provide us with the
intended information.
FPs will implement this intervention without additional
training. To ensure the questions are actually asked, we
will request the physicians to register the answers.Safety net advice We will provide a parent information
leaflet as safety net advice. It offers information about
how parents can give some comfort to their ill child,
which signs are important to follow up on and when
they should contact their physician. This leaflet was
based on literature concerning the management of fever
and alarm symptoms [19-25]. To spread uniform mes-
sages to the parents, we made sure the leaflet was in
accordance as much as possible with the information
provided by Child and Family, an agency of the Flemish
government for the well-being of young children and
their families.
To test clarity and readability we asked parents of vari-
ous education levels visiting a health care centre to read
the leaflet and mark statements that were difficult to
understand. On the basis of their remarks, we adjusted
the leaflet.
We will ask the physician to give advice by means of
this leaflet and to explain when the child should be
re-evaluated.
Only physicians of group 2 and 3 will be informed
about the content of the brief intervention and safety
net. In accordance with the cluster design, all FPs within
the same practice will belong to the same allocation
group. To avoid contamination we will explicitly ask the
physicians included in group 2 and 3 not to discuss
these interventions with their colleagues participating in
the other groups.Outcomes
1. Cluster randomized trial
Immediate antibiotic prescribing rate Physicians will
record on the registration form whether they prescribed
an antibiotic (yes/no). Besides this, they will note the
type, the dose, the reason for prescribing, whether it is a
delayed prescription (yes/no) and whether they thought
the parents wanted antibiotics (yes/no).
As a measure for tendency to prescribe antibiotics, all
physicians will complete a validated questionnaire meas-
uring their “defensive attitude score”, which expresses
the physicians’ “risk-avoiding attitude”. Physicians with
higher scores prefer the certain to the uncertain [26].
We also registered the physician’s prescribing profile
provided by the National Institute for Health and Dis-
ability Insurance (RIZIV, Belgium). This profile contains
the percentage of their patients who were prescribed an
antibiotic during 2011 and is an objective proxy for their
general antibiotic prescribing behaviour.
When comparing antibiotic prescribing rates between
the intervention groups we will take into account the phy-
sicians defensive attitude and general antibiotic pres-
cribing behaviour as possible confounders, besides other
personal characteristics (e.g. sex, age, practice type,…).
Clinical recovery Parents will record in a diary the de-
gree of sickness on a 4-point scale (not ill – moderately
ill – quite ill – very ill) and the presence of fever until
their child has recovered. On the basis of this data, we
will calculate the duration of the illness episode.
We will compare the speed of clinical recovery be-
tween children who got antibiotics and children who did
not, while taking into account the preliminary diagnosis
and clinical condition.
Parental concern Parental concern will be approached
in different ways: we will register its extent, cause and
duration throughout the illness episode.
(1) Extent of concern
After the consultation, parents will score their
degree of concern before and after the visit on a
segmented numeric version of a visual analog scale
(VAS) (0 – 10 integers). Besides this, parents will
record daily their degree of concern on a 4-point
scale (not worried – moderate worried – quite
worried – very worried) in the diary.
(2) Reason for concern
As part of the brief intervention, physicians of group
2 and 3 will record the reason for concern on the
registration form.
Besides this, all parents will complete a
questionnaire about their concerns. This survey was
developed by our research team and is based on the
Lemiengre et al. BMC Pediatrics 2014, 14:246 Page 5 of 9
http://www.biomedcentral.com/1471-2431/14/246literature about parental concern. In the
questionnaire, we will ask the parents if and where
they sought advice before contacting their physician,
what concerns them (list of conceivable reasons +
opportunity to add other reasons in free text) and how
in their opinion the physician can improve reassurance
for the parent and their child (list + opportunity to
add free text).
Furthermore, worried parents will note daily the
reason for concern in the diary.
(3) Duration of concern
On the basis of the concern score in the diary, we
will calculate the duration of the concern.
We will describe reasons for concern and compare
parental concern between (1) the intervention
groups, (2) children who received antibiotics and
children who did not, (3) children who were
referred and children who were not, (4) different
preliminary diagnoses.
Besides this, we will investigate whether the size of
the family has an influence on the extent of concern.
Parental perception of communication The Parent’s
Perception of Primary Care measure (P3C) is a practical,
reliable, and valid measure of parents’ reports of paediat-
ric primary care quality, consisting of six subscales (con-
tinuity, access, contextual knowledge, communication,
comprehensiveness and coordination). In this trial, only
the communication subscale (4 items) was used to assess
parents’ perceptions of communication. This subscale
demonstrated a good internal consistency (α = 0.83) [27].
After the consultation, parents will rate the items using
a five-point scale ranging from “never” (0) to “always”
(4). Scores will range from 0 to 16. Higher scores mean
better parental perceptions of communication [27,28].
This questionnaire was translated in Dutch forward and
backward.
We will compare the perception of communication be-
tween the intervention groups.
Parental satisfaction The Parental Medical Interview
Satisfaction Scale (P-MISS) is a measure of parent satis-
faction with the medical encounter, consisting of four
subscales (physician communication with the parent,
physician communication with the child, distress relief
and adherence intend). The P-MISS is reliable and dem-
onstrated a good construct validity [29]. In this trial, we
omitted the items that assessed the physician communi-
cation with the child, because most of the children will
be infants and toddlers. After the consultation, parents
will rate the items using a five-point Likert scale ranging
from “strongly disagree” (1) to “strongly agree” (5).
Scores on this adjusted P-MISS (16 items) can range
from 16 to 80. Lower scores indicate higher satisfactionwith care. This adjusted P-MISS total score showed
good internal consistency (α = 0.86) [27].
We will compare the parental satisfaction between the
intervention groups.
Use of medication, diagnostic tests and medical
services (including re-consultation) during the illness
episode Physicians will note the use of other diagnostic
tests (blood test, chest radiography, urine test, other
tests) and if there was a referral to a paediatrician or the
emergency department of a hospital.
Parents will record daily the use of prescribed or over
the counter (OCT) medication and whether they con-
tacted their FP, their paediatrician, a FP on duty and/or
the emergency department of a hospital.
We will compare the use of diagnostic tests and med-
ical services between the intervention groups, taking
into account the defensiveness of the physician’s pre-
scribing attitude.
Cost-effectiveness of POC CRP testing, brief
intervention with safety net advice We will balance
the costs of both interventions and the antibiotic pre-
scriptions and investigate which intervention is most
cost-effective.
2. Observational study
A number of children will be included in the large
ERNIE2-trial, but excluded in the cluster randomized
trial. For this large group of children we will obtain
all data collected on the registration forms (described
above), data on the characteristics of their physicians
and their practices. Besides this, for children included by
the family physician, we will collect data from the book-
lets. In this data we will look for predictors of antibiotic
prescribing, speed of clinical recovery, parental concern,
parental perception of communication, parental satisfac-
tion, use of medication, diagnostic tests and medical
services (including re-consultation) during the illness
episode using multivariate analysing techniques. We will
compare these results to the results of the cluster ran-
domized controlled trial.
Sample size
In order to detect an absolute reduction in antibiotic
prescribing of 15% (from 40% to 25%), with 80% power
at a 5% significance level, an individually randomized
study would need 600 patients (150 patients per group,
4 groups) (Table 1) [30].
For a cluster randomized design, standard sample size
estimates require inflation by a factor to achieve the
equivalent power of a patient randomized trial (Table 1).
This inflation factor is commonly known as the ‘design
effect’ or the ‘variance inflation factor’(VIF) [31]. To
Table 1 Sample size calculation in cluster randomised trials
Sample size (two independent groups,
dichotomous outcome variable) [30]
n = ((pC. (100 – pC) + pE. (100 – pE))/δ0
2). f(α,β) with pC = the ‘success’ rate in the control group;
pE = the ‘success’ rate in the experimental group; δ0 = pE – pC = the relevant treatment effect
to detect.
Variance inflation factor [31] VIF = 1 + (m − 1)ρ (assuming the clusters are of a similar size) with m the average cluster size; 9
ρ the estimated ICC
Intraclass Correlation Coefficient [31] This coefficient is defined as the proportion of a measure’s total variance σ 2y
 
that is shared
among members of defined clusters. The ICC takes a value of between 0 and 1.
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intraclass correlation coefficient (ICC) (Table 1). If the
treatment of patients who attend the same practice is
very consistent and there is a large variation across dif-
ferent practices, the ICC will be relatively large. In this
case it is difficult to attribute differences between the
practices to the intervention that was randomly assigned
per practice. Accounting for this kind of clustering is
important to detect effects of interventions [32].
Because calculating the exact ICCs before starting the
field study is not possible, we have to rely on reviews of
other similar cluster randomized trials. Estimates of
ICCs vary according to setting and type of outcome: esti-
mates of ICCs for process variables are higher than those
for patient outcomes, and estimates derived from sec-
ondary care are higher than those from primary care.
ICCs for process variables in primary care were of the
order of 0.05-0.15. Estimates for patient outcomes in pri-
mary care were generally lower than 0.05 [33].
We calculated the VIF for a favorable scenario (ICC =
0.05), and for an unfavorable scenario (ICC = 0.15) in
the primary care setting. Our target mean cluster size
was 21. Taking into account an ICC of 0.05, the number
of patients needed in each arm would be 328. This num-
ber increases to 640 with an ICC of 0.15. In this scope,
we will need to recruit 64 to 122 family practices.
Randomization
We intend to use stratified and block randomization.
Practices will be stratified according to practice type
(solo, duo, group). In each stratum the practices will be
divided in four blocks in order of their random number,
generated by Excel’s Random Number feature. The first
block of each stratum will be allocated to group 1, sec-
ond block to group 2, third to group 3, and the fourth to
group 4.
Implementation
Recruitment of physicians and children is described in
detail in Verbakel et al. [17].
Data collection and follow-up
We will ask the FPs to perform a thorough history, phys-
ical examination and pulse oximetry in each child and
register their findings on a case report form. For furtherdetails, we refer to Verbakel et al. [17]. At the end of the
consultation, FPs will ask parents to complete a booklet
(surveys, diary) at home until the child has recovered, to
send a text message to the investigators on the day the
child has recovered, and to post the booklet in a prepaid
envelop to the investigators.
Small incentives and regular reminders for physicians
and parents will be provided to stimulate inclusion rates
and achieve complete data collection. More details are
described in Verbakel et al. [17].
Statistical analysis
The data will be stored and analyzed at two locations,
KU Leuven and Ghent University, using Excel (Microsoft
Corporation, Redmond, USA), Stata software (version 11.2;
Stata Corp., College Station, TX, USA), SPSS (version 20;
SPPS Inc., Chicago, Illinois, USA) and QSR NVivo version
10 (QSR International Pty Ltd, Melbourne, Australia).
Preliminary diagnoses and reasons for encounter will be
classified using the International Classification of Primary
Care (ICPC-2) [34]. Prescribed and OTC medication will
be categorized using the Anatomical Therapeutic Chem-
ical (ATC) Classification System [35].
Two investigators will independently code the reasons
for concern and antibiotic prescribing following appro-
priate qualitative research methods.
The primary analysis will assess the effect of the two
interventions on the primary and secondary outcome
measures, using a three level logistic (dichotomous vari-
ables) or linear (continuous variables) regression model
where appropriate, to account and correct for variation
at the level of the practice (size, location, training prac-
tice), family physician (defensive attitude or general anti-
biotic prescribing behaviour, age, sex, years of experience,
being in vocational training, graduated and/or vocational
trainer) and patient (preliminary diagnosis, social back-
ground, size of the family, day of the week at inclusion).
We will incorporate an interaction term to test for a syn-
ergistic (or antagonistic) relationship between the two
interventions.
Besides this, we will observationally investigate the
data of children included in the large ERNIE2-trial, but
excluded in the cluster randomized trial. We will search
predictors for antibiotic prescribing, reasons for concern
and other secondary outcome measures as described
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the cluster randomized controlled trial.
Discussion
This cluster randomized controlled trial will be the first
to evaluate the effect of a POC CRP test and a simple
communicative intervention with safety net advice on
the antibiotic prescribing rate in acutely ill children not
suspected of serious disease in primary care.
A Cochrane review investigating the effect of interven-
tions to change the antibiotic prescribing behaviour found
that multi-faceted interventions combining physician,
patient and public education were the most successful
in reducing antibiotic prescribing for inappropriate
indications [36]. This intervention fulfils this condition
by targeting both the physician’s and parental uncer-
tainty: physicians are provided with a technical and
communicative tool and parents receive clear informa-
tion. Public education is not part of our intervention, but
during this trial the annual national public health cam-
paign to increase the awareness of the negative conse-
quences of inappropriate antibiotic use (TV spots, folders,
national antibiotic awareness day) will take place.
In the scope of the large ERNIE2-trial, we identified
CRP as the most probable candidate to detect serious
infections in febrile children in ambulatory settings
and reduce irrational antibiotic prescribing. The Afinion
AS100 Analyzer (Alere, USA) is a very user-friendly de-
vice, especially because a small drop of blood is enough to
perform the test, making it perfect to use in children, and
only two simple operations are needed to get the result
(aspirating blood in the capillary, putting the cassette in
the machine). Since currently, in children, there are no
reliable cut-offs for CRP allowing to discriminate viral
from bacterial causes, nor serious from non-serious
illnesses, physicians did not receive any guidance on the
interpretation of the CRP results, nor on the manage-
ment. Finding reliable cut-offs is one of the goals of the
ERNIE2-trial (part A) [17].
We are opting for a very simple communicative inter-
vention to find out the worries of the parents by asking
three short questions and handing out an information
leaflet with alarm symptoms as safety net. We believe
that a better knowledge of the ideas, concerns and ex-
pectations of the parents will help the physician to ex-
plain his preliminary diagnosis and treatment choices to
the parents and draw attention to the alarm signs they
should follow up on. We will ask the physicians to note
the answers of the communicative intervention, so that
we can ensure the questions were asked. We believe that
this will help the physician to reassure parents, without
an antibiotic prescription. Moreover, this trial will give
us insight into parental reasons for concern. The existing
trials investigating the worries of parents are rather old.New available sources of information (e.g. the internet)
could have changed the nature of their concerns and
information needs.
As far as we know, this combined intervention has
never been executed before. We chose a simple inter-
vention that can be implemented without training. We
decided to make our leaflet corresponding to the infor-
mation provided by Child and Family, which is an influ-
ential organization in Flemish health care. In this way
we hoped to avoid that differences between information
sources would lead to confusion and more uncertainty
in parents.
We aim to include 2560 patients (following the un-
favorable scenario), which should give the study enough
power to yield clear significant results. The broad inclu-
sion criterion will make the results applicable for a large
group of acutely ill children attending in primary care.
We believe that it will be possible to recruit such large
number of children as acute illness in children is a very
common reason for primary care encounters.
Randomization at practice level was chosen to avoid
contamination of our communicative intervention. We
will explicitly ask the physicians included in group 2 and
3 not to discuss this interventions with their colleagues
participating in the other groups.
Recruitment rates across the four groups will be moni-
tored closely. Practices recruiting poorly will be replaced.
A multi-level analysis will be performed to take into
account confounders, including defensive attitude or
general antibiotic prescribing behaviour and preliminary
diagnosis, which can influence the results. Results will
be reported according to the Consort 2010 statement for
reporting of cluster randomized trials [18].
POC CRP testing has previously been shown to reduce
antibiotic prescribing in upper respiratory tract infec-
tions [37]. A trial with a similar design, combining POC
CRP testing and a communicative intervention reduced
antibiotic prescribing in coughing adults [38]. In this
trial, we will test a similar intervention in acutely ill chil-
dren. Still, we made some other choices concerning the
interventions. Because of the lack of reliable cut-offs for
CRP-testing in acutely ill children, physicians did not
receive any guidance on the interpretation of the CRP
results. Secondly, we choose not to actively train the
family physicians to elicit patients’ concerns about their
illness because we believe that interventions with train-
ing are difficult to implement afterwards. Moreover, the
sample size will be considerably larger to yield enough
power to compare the 4 treatment arms separately.
As far we know, the effect of a combination of a sim-
ple communicative intervention (without training) and
a leaflet on antibiotic prescribing was not investigated
before. A clustered randomized controlled trial found
that the use of a interactive booklet alone on respiratory
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ant reductions in antibiotic prescribing and the intention
to consult without reducing parental satisfaction with
care [39]. This intervention is similar, but differs at
several points. In the trial of Francis et al, physicians
were actively trained online to use the booklet to facili-
tate the use of certain communication skills. As stated
above, our physicians were not trained. Contrary to
our leaflet, the booklet focuses on upper respiratory
tract infections instead of the general management of
ill children and alarm symptoms.
If these interventions decrease the antibiotic prescrib-
ing rate or have favorable effects on parental concern
and satisfaction, we will perform a cost-effectiveness
analysis to evaluate the consequences of the intervention
on the health care budget.
If the balance for one or more interventions is advan-
tageous on irrational antibiotic prescribing and conse-
quently on antibiotic resistance, we will promote the
interventions in daily care by implementing them in
guidelines and apply for reimbursement of POC CRP test-
ing within the national health insurer for reimbursement.
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